Please ensure Javascript is enabled for purposes of website accessibility
Home / Products / Antibody / Recombinant Antibody

Anti-PPP1R1B Antibody (R4A44)

Catalog #:   RHN83102 Specific References (26) DATASHEET
Host species: Mouse
Isotype: IgG1
Applications: ELISA, FCM
Accession: Q9UD71
Overview

Catalog No.

RHN83102

Species reactivity

Human

Host species

Mouse

Isotype

IgG1

Clonality

Monoclonal

Tested applications

ELISA: 1:10000, FCM: 1:200-1:400

Target

PPP1R1B, Protein phosphatase 1 regulatory subunit 1B, DARPP32, Dopamine- and cAMP-regulated neuronal phosphoprotein, DARPP-32

Concentration

1 mg/ml

Endotoxin level

Please contact with the lab for this information.

Purity

>95% as determined by SDS-PAGE.

Purification

Protein A/G purified from cell culture supernatant.

Accession

Q9UD71

Applications

ELISA, FCM

Form

Liquid

Storage buffer

0.01M PBS, pH 7.4, 0.05% Sodium Azide.

Stability and Storage

Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C short term (1-2 weeks). Store at -20°C 12 months. Store at -80°C long term.

Clone ID

R4A44

Data Image
  • Flow Cytometry
    Flow cytometric analysis of Hela cells using PPP1R1B mouse mAb (green) and negative control (red).
References

DARPP-32 and t-DARPP in the development of resistance to anti-HER2 agents. Pre-clinical evidence from the STEP study., PMID:37769528

Transcriptome and chromatin landscape changes associated with trastuzumab resistance in HER2+ breast cancer cells., PMID:34224831

Dopamine and cAMP-regulated phosphoprotein 32 kDa (DARPP-32) and survival in breast cancer: a retrospective analysis of protein and mRNA expression., PMID:31740718

t-Darpp Activates IGF-1R Signaling to Regulate Glucose Metabolism in Trastuzumab-Resistant Breast Cancer Cells., PMID:29180608

t-Darpp stimulates protein kinase A activity by forming a complex with its RI regulatory subunit., PMID:28867659

The Intracellular Signaling Molecule Darpp-32 Is a Marker for Principal Neurons in the Cerebellum and Cerebellum-Like Circuits of Zebrafish., PMID:27540357

Human t-DARPP is induced during striatal development., PMID:27475250

Functional variants of 17q12-21 are associated with allergic asthma but not allergic rhinitis., PMID:26483175

Gastric tumour-derived ANGPT2 regulation by DARPP-32 promotes angiogenesis., PMID:25779598

Experimental traumatic brain injury alters ethanol consumption and sensitivity., PMID:24934382

Mutant huntingtin gene-dose impacts on aggregate deposition, DARPP32 expression and neuroinflammation in HdhQ150 mice., PMID:24086450

DARPP-32 to quantify intracerebral hemorrhage-induced neuronal death in basal ganglia., PMID:23543809

Regulation of ERBB2 receptor by t-DARPP mediates trastuzumab resistance in human esophageal adenocarcinoma., PMID:22745369

Detailed DARPP-32 expression profiles in postmortem brains from patients with schizophrenia: an immunohistochemical study., PMID:22179181

Colocalization of somatostatin receptors with DARPP-32 in cortex and striatum of rat brain., PMID:22116741

Levodopa treatment improves functional recovery after experimental stroke., PMID:22096034

Altered DARPP-32 expression in the superior temporal gyrus in schizophrenia., PMID:21453742

Distinct subclasses of medium spiny neurons differentially regulate striatal motor behaviors., PMID:20682746

In vivo expression of polyglutamine-expanded huntingtin by mouse striatal astrocytes impairs glutamate transport: a correlation with Huntington's disease subjects., PMID:20494921

Darpp-32 and its truncated variant t-Darpp have antagonistic effects on breast cancer cell growth and herceptin resistance., PMID:19593441

Colocalization of dopamine receptor subtypes with dopamine and cAMP-regulated phosphoprotein (DARPP-32) in rat brain., PMID:19465068

Both t-Darpp and DARPP-32 can cause resistance to trastuzumab in breast cancer cells and are frequently expressed in primary breast cancers., PMID:19301121

Anti-DARPP32 antibody-immunopositive inclusions in the brain of patients with multiple system atrophy., PMID:18808062

A cellular mechanism for dendritic spine loss in the pilocarpine model of status epilepticus., PMID:18479390

General anesthetics selectively modulate glutamatergic and dopaminergic signaling via site-specific phosphorylation in vivo., PMID:17826804

Disruption of reelin signaling attenuates methamphetamine-induced hyperlocomotion., PMID:17553006

Datasheet
$ 220
Product specifications
50 μg 220 100 μg 350

Contact Information

Order: order@antibodysystem.com

Mail: support@antibodysystem.com

Distributor list

For research use only. Not for human or drug use.

Need help with your order?

Find out more about placing an order here

Anti-PPP1R1B Antibody (R4A44) [RHN83102]
Terms of sale Website terms of use Cookie policy Privacy
Copyright © 2025 AntibodySystem SAS. All Rights Reserved.            All Products are for Research Use Only